Apervita Establishes First Cloud-Based Healthcare Platform for Payers and Providers to Offer Deep Encryption of Health Data

CHICAGO, March 26, 2020 /PRNewswire/ — Apervita, the leading platform for value-based collaboration in healthcare, today announced they are offering Deep Encryption™ to their health plan and provider customers. The new feature introduces an unprecedented level of security to the U.S. healthcare system by encrypting data at the field level. Personal health information is not just protected at the level of a database but down to the components of individual health records that make up the database—records containing information such as insurance claims, medications, test results, and diagnoses. This extends the level of protection beyond what is currently mandated HITRUST and HIPAA requirements. Apervita is the first healthcare company to offer this level of encryption security technology.

As the healthcare industry continues to move to electronic forms of data, opportunities for data breaches also increase. In fact, the number of patient records more than doubled in 2019 with 32 million patients compromised. The financial implications of such breaches are enormous, with estimates as high as $429 per breached record, not to mention the life-threatening impact to patient safety that can occur when records are breached.

“Deep Encryption is a game changer for our customers,” said Michael Oltman, Apervita’s chief technology officer. “As a healthcare platform that works with over 2,500 U.S. hospitals, security is our top priority. Deep Encryption not only protects data far beyond typical data security requirements, it returns control of the data to our customers. We’re offering exactly what our customers want: security, safety, and control.”

“Especially in today’s world, with more people working remotely, we have learned to trust the cloud,” said Michael Semel, CSCS, CHP, CHSP, CBCP and President of Semel Consulting. “Deep encryption technology protects PHI in the cloud and hands over control to the client with a security key. This is the most sophisticated level of data security that most healthcare organizations are missing in their own systems.”

Additionally, Apervita’s Deep Encryption feature meets requirements of the Office of the National Coordinator’s (ONC) recent Information Blocking final rule, which calls for granular, PHI field-level privacy to support data segmentation, while still allowing for data to be accessible.

The security of Apervita’s customer’s PHI data is of primary importance and was the catalyst to implement the deepest encryption in the industry. With the recent release of Field Level Encryption (FLE) by MongoDB, Apervita’s database partner, Apervita was able to dramatically decrease the time needed to build the full Deep Encryption solution, which adds multiple layers to the FLE feature to enable unique encryption per customer dataset. The Deep Encryption feature also provides customers with a BYOK (Bring-Your-Own-Key) capability, which gives customers full control and ownership of their data on a per customer and per dataset level. 

“Apervita’s platform is ideal for implementing Client Side Field Level Encryption, and helps advance healthcare IT data security,” said Kenn White, Security Principal at MongoDB. “We’re thrilled to see their quick adoption of this unique capability and look forward to witnessing the impact it will have in protecting the most sensitive workloads in the industry.”

Implementing additional security measures is top-of-mind for all healthcare executives, but the cost and complexity of implementing greater security has deterred many organizations. Apervita’s platform was already designed and built to support Deep Encryption, creating seamless integration with its products. Apervita can easily enable this feature for any of the 2,500+ hospitals already on the Apervita platform, increasing their peace of mind that their data is secure.

Apervita, the Apervita logo and Deep Encryption are trademarks or registered trademarks of Apervita, Inc. All Rights Reserved.

About Apervita
Apervita is the trusted collaboration platform for value-based healthcare. We empower payers and providers and other stakeholders to more efficiently and effectively measure clinical and financial performance, improve clinical quality and administer value-based contracts. By providing an independent, secure, trusted platform to perform shared analyses, Apervita uniquely allows stakeholders to gain mutual, continuous clinical and financial insights and integrate those insights in various systems and workflows simultaneously and at scale. Serving more than one in three hospitals in the United States and several nationally recognized health plans, Apervita conducts more than 10 billion value-based computations and insights for our clients every year. The company maintains office locations in Chicago and Boston.

Media contact: 

Michelle Schallhorn
Vice President, Marketing
michelle.schallhorn@apervita.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/apervita-establishes-first-cloud-based-healthcare-platform-for-payers-and-providers–to-offer-deep-encryption-of-health-data-301029863.html

SOURCE Apervita, Inc.

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

3 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

3 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

3 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

3 hours ago